Bli medlem
Bli medlem

Du är här



Carlsbad, California, April 28, 2015
- Aurora Spine Corporation (TSXV: ASG) announced today the first surgical
implantations of the company's ZIP 51(TM) Minimally Invasive Interspinous
Implant in the United States and Germany.

The U.S. surgery was performed at NEA Baptist Memorial Hospital in Jonesboro,
Arkansas by Dr. Rebecca Barrett-Tuck. The international surgery was performed
at the Protestant Hospital in Göttingen, Germany by Dr. Christian Reparon.

"The ZIP 51 MIS interspinous fusion system is a great option for the L5-S1
segment," said Dr. Reparon. The instrumentation is very intuitive, easy to
use and the implantation is fast and simple via a small incision."

"Aurora Spine's ZIP 51(TM) implant, the newest addition to the ZIP(TM)
product line, was developed to deliver rigid stabilization with bone graft at
the L5-S1 level of the human spine," said Laszlo Garamszegi, Aurora Spine's
CTO. "Aurora Spine is pleased to offer the ZIP 51 implant as a distinctive
sacral fusion option to surgeons and patients worldwide as part of the Aurora
Spine Screwless Procedure(TM)."

"We are very excited to offer our ZIP 51 device internationally," said Sven
Claes, International Product Director of Aurora Spine. "The implant features
flared lower spikes which are designed to increase the possibility of greater
bone purchase. Like our ZIP ULTRA(TM) implant, the ZIP 51 MIS interspinous
fixation implant for spinal fusion, consists of the ZIP ONE-STEP(TM) Locking
Mechanism, and various sizes to accommodate variations in patient anatomy
which eliminates the use of a set screw."

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to
the spinal implant market through a series of innovative, minimally invasive,
regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves
substantial known and unknown risks and uncertainties, most of which are
beyond the control of Aurora Spine, including, without limitation, those
listed under "Risk Factors
" and "Cautionary Statement Regarding Forward-Looking Information
" in Aurora Spine's final prospectus (collectively, "forward-looking
information"). Forward-looking information in this news release includes
information concerning the proposed use and success of the company's products
in surgical procedures. Aurora Spine cautions investors of Aurora Spine's
securities about important factors that could cause Aurora Spine's actual
results to differ materially from those projected in any forward-looking
statements included in this news release. Any statements that express, or
involve discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance are not historical facts and may
be forward-looking and may involve estimates, assumptions and uncertainties
which could cause actual results or outcomes to differ unilaterally from
those expressed in such forward-looking statements. No assurance can be given
that the expectations set out herein will prove to be correct and,
accordingly, prospective investors should not place undue reliance on these
forward looking statements. These statements speak only as of the date of
this press release and Aurora Spine does not assume any obligation to update
or revise them to reflect new events or circumstances.

For more information, please contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Eric Fronk
Chief Financial Officer
(760) 424-2004


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aurora Spine Corporation via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.